The women’s health dividend: closing the gap for a healthier, wealthier world

5 Mar 2026

Stethoscope and rose petals in the shape of the Venus symbol

Achieving good health is more than a medical expense. It is an investment in our future, and this is especially true today for women's health and well-being. Globally, women spend about 25% more of their lives in poor health than men,[1] creating a gap that is not only a moral concern but also a significant economic challenge. Recent research estimates that improving women's health could add 75m healthy life-years a year, equivalent to seven extra healthy days per woman per year, and increase global GDP by $1trn by 2040.[2] This “health dividend” underscores the enormous benefit of investing in women's health and well-being.

Women's health covers a range of issues, from maternal and reproductive health to critical challenges such as breast and cervical cancers. It also includes less obvious but significant aspects, such as fertility challenges, which increasingly affect women and families globally but are often neglected by public policy. Similarly, workplace-support policies, including flexible working arrangements and fair parental leave are essential not only for women's health and well-being but also for broader economic stability and growth, to help women remain in work and thrive, and be their most productive.

Maternal health and fertility: foundations for society

Ensuring safe motherhood is vital. Between 2000 and 2023, global maternal mortality fell by 40%, yet every day in 2023 more than 700 women died from preventable causes related to pregnancy and childbirth—nearly one death every two minutes.[3] Strengthening maternal health care, especially in low-income countries, can save tens of thousands of mothers a year, enabling them to support their families and create healthier future generations.

Meanwhile, declining global fertility rates are creating economic problems, such as worker shortages and ageing populations—challenges highlighted in recent Economist Enterprise reports on falling fertility rates in the Asia-Pacific region: Fertility policy and practice: the APAC fertility and family Scorecard and Europe: Fertility policy and practice: a toolkit for Europe. Rather than pressuring women to have more children, these reports argue for empowering women to achieve their desired family size without sacrificing economic security. But to achieve this, change is needed, and investing in comprehensive family-support policies including subsidised childcare, paid parental leave and workplace flexibility has proved effective. Our research in Europe shows that these investments produce a dual benefit: higher fertility rates (important for future economic gains), and greater participation by women in the workforce (important for now).

Family-friendly policies also deliver a strong economic return by reducing the “opportunity cost” of having children and enabling women to continue in their careers. Countries such as Sweden have shown success in tackling fertility challenges through their comprehensive and family-friendly policies, with generous leave systems allowing both parents to balance work and family without sacrificing career continuity. Similarly, Japan has targeted raising fertility rates through substantial public investment in family support, including expanding childcare facilities and providing access to assisted reproductive technologies such as in vitro fertilisation (IVF). More examples can be explored in our article Supporting families: the role of workplace policies in addressing declining birth rates.

An emerging and significant aspect of reproductive health is elective egg freezing, a medical innovation offering women greater flexibility in planning families, allowing them to preserve their fertility for non-medical reasons such as career advancement, education, financial stability or not having found the right partner. Its uptake has risen, particularly as fertility rates decline and women delay childbearing, as explored in our article The rise of egg freezing: empowering women's reproductive choices in the Asia-Pacific region. In Australia, for instance, the number of women freezing their eggs increased by 818% between 2012 and 2021, highlighting its growing popularity. By allowing women more control over their reproductive timelines, egg freezing can help reduce involuntary childlessness, a challenge faced by an increasing number of families worldwide. However, there remains a need for greater awareness, equitable access and supportive funding models to ensure all women, irrespective of their socioeconomic status, can benefit from this technology.

Addressing women’s cancers

Investing in the prevention and treatment of women's cancers, particularly breast and cervical cancers, is essential—not only from a public-health perspective but also as a strategic economic investment. These cancers disproportionately affect women globally, significantly impacting economic productivity and leading to substantial costs on healthcare systems and society as a whole.

Breast cancer is the most frequently diagnosed cancer worldwide, with over 2m new cases annually, and incidence rates are rising rapidly, especially in developing regions. In Asia, the incidence of breast-cancer is projected to rise by about 17% by 2030, with mortality expected to increase by 22%.[4] Direct medical costs combined with lost productivity due to breast cancer significantly strain economies across the Asia-Pacific region, as explored in our report Impact and opportunity: the case for investing in women’s cancers in Asia-Pacific. In Thailand, for example, treatment costs per patient escalate dramatically from about $10,400 for early-stage disease to more than $63,000 for advanced stages, highlighting the critical economic importance of early detection and effective treatment strategies.[5] A recent systematic review of women with breast cancer found that lost productivity due to premature death ranged from $22,386 to $52bn, and productivity lost due to morbidity ranged from $127m to $597m.[6] Because advanced-stage breast cancer is typically associated with much greater costs, both direct and indirect, investing in preventive measures and organised screening programmes, as well as awareness and education campaigns to improve early diagnosis, can make a huge difference.

Cervical cancer is also a significant global health challenge, affecting more than 604,000 women and leading to 342,000 preventable deaths worldwide.[7] But it is uniquely positioned for elimination through comprehensive strategies including human papillomavirus (HPV) vaccination, regular screening and timely treatment. The World Health Organisation’s (WHO) global cervical cancer elimination strategy has set targets of 90% HPV-vaccination coverage, 70% screening rates and 90% treatment coverage by 2030. The WHO estimates that for every dollar invested in interventions to help meet these 90-70-90 elimination targets (such as immunisation and screening), more than $3 would be returned to the economy, and eliminating cervical cancer could keep a quarter of a million women in the global workforce, adding approximately $28bn a year to the global economy.[8]

Economist Enterprise research underscores the extensive benefits of scaling cervical cancer prevention programmes. Our report A global blueprint for cervical cancer elimination: learnings from Sweden explores how countries like Sweden are leading the way towards cervical cancer elimination through effective HPV vaccination and nationwide screening programmes, which are resulting in significant cost savings and improved health outcomes. Lower-middle-income countries, however, still face challenges due to limited screening coverage, inadequate healthcare infrastructure and insufficient public awareness, showing the need for international support and investment in these regions.

Chronic conditions: reducing burdens, enhancing productivity

Chronic non-communicable diseases primarily affect women in their prime working years, reducing their productivity and quality of life, and many conditions, including migraine headaches, cardiovascular disease, depression, thyroid conditions and osteoporosis, disproportionately affect women compared with men. For instance, depression is nearly twice as prevalent in women as in men.[9] Tackling some of the most common chronic conditions such as migraines, premenstrual syndrome (PMS) and depression would not only help with individual suffering but would also contribute significantly to economic productivity. Better management of PMS alone could contribute an estimated $115bn annually to the global economy through increased productivity and reduced absenteeism.[10]

Osteoporosis, which disproportionately affects older women, can lead to significant medical costs and lost productivity through increased fracture risks. Investments in early screening, preventive care and targeted treatments are crucial to help women maintain independence, mobility and keep working as they age. Women, especially during pregnancy and older age, are also among the most high-risk groups for thyroid disease. This disease is often underdiagnosed and has been shown to reduce quality of life, exacerbate other chronic conditions and impose major economic costs if left untreated, as explored in our report Closing the gap: prioritising thyroid disease in Asia-Pacific. Tackling these chronic conditions proactively offers substantial returns in health, social well-being and economic productivity, underscoring the importance of integrating chronic-disease management into comprehensive women’s health strategies.

Conclusion

Improving women’s health is a significant global opportunity that can help drive societal and economic progress. Treating women’s health as an investment through improved maternal care, fertility support, cancer prevention and treatment and chronic-disease management can change billions of lives, create stronger families and improve economic growth. The Bill and Melinda Gates Foundation recently announced a $2.5bn commitment through to 2030 to accelerate research and development focused exclusively on women’s health. It is urging governments, philanthropists, investors and the private sector to co-invest in women’s health innovations, calling this “An investable opportunity with immense potential”. By prioritising women's health, we can unlock substantial economic benefits and have more inclusive and resilient societies, not only improving health outcomes but also advancing gender equity. Realising the women’s health dividend today ensures a healthier, wealthier and more equitable world tomorrow.

References